Stock screener

DMAC

Conviction 49HealthcareScan · Mon, Aug 10, 2026
DMAC$6.65-1.48%
ResistanceSupportVol 14
63 bars
Vol MA14 179.26K
May 11May 28Jun 16Jul 6Jul 23Aug 10
DiaMedica Therapeutics Inc.PHARMACEUTICAL PREPARATIONSwww.diamedica.com
Price6.65
Change-1.48%
Gap-0.22%
Rel volume2.34×
Avg volume183.44K
Avg $ vol1.25M
SMA 206.83
SMA 506.58
SMA 2007.19
Price vs 50+1.06%
Price vs 200-7.53%
MA stackmixed
50/200 cross
Supertrenddown · 7.63
RSI (14)47
MACD hist-0.03
MACD cross
Stoch %K / %D46 / 49
ADX (14)18
+DI / −DI16 / 20
RSI divergence
MACD divergence
ATR %+5.48%
ADR %5.23%
52w high9.39
52w low4.58
From 52w high-29.18%
Above 52w low+45.20%
New 52w highNo
SqueezeOff
Bollinger width20.04%
%B0.37
Donchian pos27.21%
Donchian high7.72
Donchian low6.25
AVWAP (52w high)7.40
vs AVWAP high-10.10%
AVWAP (52w low)7.15
vs AVWAP low-7.05%
OBV trendDown
Chaikin MF (20)-0.10
Today vs 20d2.34×
Avg vol (14d)179.26K
Avg vol (20d)183.44K
Avg $ vol (20d)1.25M
Market cap
RS 3m (vs SPY)-2.33%
RS 6m (vs SPY)-24.59%
RS line new highNo
Trend template2/8
Technical rank23.8
1 week+1.99%
1 month-13.30%
3 months+5.22%
6 months-18.30%
1 year+37.97%
YTD-16.14%
P/E-11.08
P/B7.69
P/S726.35
P/FCF-12.48
EPS-0.6500
Div yield
ROE-69.37%
ROA-61.73%
Debt/Eq
Current9.11
EV/EBITDA
Gross margin
Net margin
Rev growth0.00%
EPS growth-34.05%
Price target
Target upside
Analyst rating
Institutional
Ent. value358.31M
Revenue500K
Net income-10.04M
Gross profit
Free cash flow-29.1M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out53.88M
Employees35
ListedThu, Nov 29, 2007
Free float
Float %
Short interest
Days to cover
Short volume
Squeeze score
Next earnings
EPS forecast
Last EPS vs est
Last surprise
Setup gradeC
Conviction49 / 100
Pattern quality
Tech rank23.8 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction
Pattern family
Resistance7.83
Support5.69
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 46 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

  1. Setting up
    Aug 4
    1 scan
  2. Breaking out now
    Aug 5
    1 scan

Congress activity

Disclosed STOCK Act trades in DMAC

All disclosures →
No recent disclosed trades by Congress in DMAC. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in DMAC · 9 buys

InsiderSideShares
Kuntz Richard
Director · Stock Option (right to buy) · 2026-06-01
Grant40.41K
Parsons James T.
Director · Stock Option (right to buy) · 2026-06-01
Grant51.19K
Semba Charles Pauling
Director · Stock Option (right to buy) · 2026-06-01
Grant40.41K
Giuffre Randall Michael
Director · Stock Option (right to buy) · 2026-06-01
Grant40.41K
Kellen Scott
CFO & Secretary · Stock Option (right to buy) · 2026-06-01
Grant162K
O'Connor Daniel J.
Director · Stock Option (right to buy) · 2026-06-01
Grant40.41K
Krop Julie
Chief Medical Officer · Stock Option (right to buy) · 2026-06-01
Grant67.5K
Lewis Tanya
Director · Stock Option (right to buy) · 2026-06-01
Grant40.41K
Pauls Dietrich John
President & CEO · Stock Option (right to buy) · 2026-06-01
Grant380K

SEC filings

EDGAR filings in DMAC

EDGAR →

No recent SEC filings on file for DMAC.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.